相关实验视频
Updated: Jun 4, 2025

06:40
Seven Steps to Stellate Cells
Published on: May 10, 2011
33.8K
利用核受体调节肝星细胞激活,以解决肝纤维化
Yaxin Sun1, Xiaoyan Yuan1, Zhenhua Hu2
1Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China; University of Chinese Academy of Sciences, Beijing, China.
Biochemical pharmacology
|December 22, 2024
概括
核受体为肝纤维化提供了新的治疗途径,特别是在代谢功能障碍相关的脂肪肝炎 (MASH) 中. 准这些受体以控制肝星细胞 (HSC) 激活显示出治疗肝纤维化的各种原因的希望.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 细胞生物学 细胞生物学
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 和与之相关的肝纤维化是一个日益增长的临床挑战.
- 虽然Resmetirom针对MASH的核受体,但其他原因的纤维化治疗的有效治疗方法有限.
- 肝星细胞 (HSC) 激活是肝纤维化病原体的关键驱动因素.
研究的目的:
- 审查核受体在HSC激活中的结构,功能和作用.
- 探索针对肝纤维化的核受体向药物开发的最新进展.
- 为了确定潜在的新核受体点,以解决肝纤维化.
主要方法:
- 系统审查关于核受体和肝纤维化的科学文献.
- 分析核受体和HSC激活通路之间的相互作用.
- 讨论针对核受体的当前和新兴治疗策略.
主要成果:
- 核受体在调节HSC激活方面发挥着多方面的作用.
- 针对核受体提供了一个合理的方法来调节HSC激活.
- 最近的药物开发突出了核受体在肝纤维化中的治疗潜力.
结论:
- 通过核受体调节HSC激活是一种有前途的策略,用于治疗各种肝纤维状况.
- 对HSC中特定核受体标的进一步研究可能会导致新的治疗方法.
- 本综述为了解和开发基于核受体的肝纤维化治疗方法提供了一个框架.
相关概念视频
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K

